IPO - Profile


We are an innovative life sciences technology company delivering spatial biology solutions focused on transforming discovery and clinical research. Our mission is to deliver a revolutionary new class of spatially derived biomarkers that empower life sciences researchers to better understand disease and clinicians to improve patient outcomes. Spatial biology refers to a rapidly evolving technology that enables academic and biopharma scientists to detect and map the distribution of cell types and biomarkers across whole tissue samples at single cell resolution, enabling advancements in their understanding of disease progression patient response More

Offer Price Offer Size 3-Year Outlook Volatility First Day Turnover
$20.00 6,580,000 Positive High 57.81%

Offering Team

  • Legal counsel
  • DLA Piper LLP
  • Auditors

Deal Highlights

Deal Tracker

IPO Dates

Filing 12 Apr, 2021

Offer 16 Apr, 2021

Look Ahead

Lock Up Expiry Oct 16, 2021

IPO Terms

Offer Price $20.00
Offer Size 6M

Market Sentiments

Stock Price